Q3 2026 13F filing
Updated 6 days ago124 disclosed positions worth $5.5B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | E EDGEWISE THERAPEUTICS INC | $630.1M | 15.52M | 11.46% | — |
| 2 | A ADARX PHARMACEUTICALS INC | $482.7M | 24.21M | 8.78% | — |
| 3 | E ENLIVEN THERAPEUTICS INC | $310.6M | 6.78M | 5.65% | — |
| 4 | L ELI LILLY & CO | $298.4M | 257.9K | 5.43% | — |
| 5 | ? N/A BRAVEHEART BIO INC | $245.9M | 12.18M | 4.47% | — |
| 6 | S SINOVAC BIOTECH LTD | $195.5M | 2.72M | 3.56% | — |
| 7 | M MBX BIOSCIENCES INC | $180.2M | 3.07M | 3.28% | — |
| 8 | M MERCK & CO INC | $137.5M | 946.1K | 2.50% | — |
| 9 | G GUARDANT HEALTH INC | $104.2M | 584.1K | 1.89% | — |
| 10 | A ARRIVENT BIOPHARMA INC | $91.7M | 3.03M | 1.67% | — |
| 11 | C CORVUS PHARMACEUTICALS INC | $82.5M | 7.17M | 1.50% | — |
| 12 | N NATERA INC | $82.5M | 199.7K | 1.50% | — |
| 13 | A ARCUTIS BIOTHERAPEUTICS INC | $82.5M | 3.12M | 1.50% | — |
| 14 | T THERMO FISHER SCIENTIFIC INC | $81.3M | 120.4K | 1.48% | — |
| 15 | U UNITEDHEALTH GROUP INC | $80.4M | 219.0K | 1.46% | — |
| 16 | A ASCENDIS PHARMA A/S | $78.6M | 345.2K | 1.43% | — |
| 17 | ? N/A ELECTRA THERAPEUTICS INC | $77.5M | 6.89M | 1.41% | — |
| 18 | A ARGENX SE | $72.1M | 75.2K | 1.31% | — |
| 19 | E EDWARDS LIFESCIENCES CORP | $72.1M | 834.9K | 1.31% | — |
| 20 | T TRAVERE THERAPEUTICS INC | $70.7M | 1.20M | 1.29% | — |
| 21 | T TANGO THERAPEUTICS INC | $69.3M | 2.78M | 1.26% | — |
| 22 | A ABBVIE INC | $67.9M | 259.6K | 1.24% | — |
| 23 | C CARIS LIFE SCIENCES INC | $67.2M | 2.19M | 1.22% | — |
| 24 | O ODYSSEY THERAPEUTICS INC | $66.7M | 3.00M | 1.21% | — |
| 25 | C COGENT BIOSCIENCES INC | $64.2M | 2.00M | 1.17% | — |
| 26 | A ASTRAZENECA PLC | $61.8M | 379.3K | 1.12% | — |
| 27 | C CAREDX INC | $60.8M | 934.8K | 1.11% | — |
| 28 | P PRAXIS PRECISION MEDICINES I | $58.4M | 200.4K | 1.06% | — |
| 29 | A ABBOTT LABORATORIES | $57.2M | 579.0K | 1.04% | — |
| 30 | P PRELUDE THERAPEUTICS INC | $53.7M | 13.72M | 0.98% | — |
| 31 | ? N/A BLOSSOMHILL THERAPEUTICS INC | $50.6M | 2.71M | 0.92% | — |
| 32 | H HUMANA INC | $48.8M | 127.8K | 0.89% | — |
| 33 | S SHATTUCK LABS INC | $43M | 6.31M | 0.78% | — |
| 34 | G STRUCTURE THERAPEUTICS INC | $41.6M | 1.33M | 0.76% | — |
| 35 | U UROGEN PHARMA LTD | $40.2M | 988.5K | 0.73% | — |
| 36 | I INTUITIVE SURGICAL INC | $39.4M | 96.8K | 0.72% | — |
| 37 | R RHYTHM PHARMACEUTICALS INC | $38.8M | 408.0K | 0.71% | — |
| 38 | M MINERALYS THERAPEUTICS INC | $36.6M | 1.45M | 0.66% | — |
| 39 | S ARS PHARMACEUTICALS INC | $35.7M | 8.29M | 0.65% | — |
| 40 | Q Q32 BIO INC | $34.1M | 4.13M | 0.62% | — |
| 41 | K KRYSTAL BIOTECH INC | $32.5M | 97.7K | 0.59% | — |
| 42 | P PALVELLA THERAPEUTICS INC NE | $31.7M | 229.9K | 0.58% | — |
| 43 | A AXSOME THERAPEUTICS INC. | $31.5M | 170.9K | 0.57% | — |
| 44 | J JAZZ PHARMACEUTICALS PLC | $30.4M | 131.1K | 0.55% | — |
| 45 | ? N/A UPSTREAM BIO INC | $30M | 5.69M | 0.55% | — |
| 46 | W WEST PHARMACEUTICAL SVSC INC | $29.7M | 80.2K | 0.54% | — |
| 47 | ? N/A LATIGO BIOTHERAPEUTICS INC | $28M | 1.68M | 0.51% | — |
| 48 | C CELCUITY INC | $25M | 314.5K | 0.45% | — |
| 49 | ? N/A SCRIBE THERAPEUTICS INC | $24.8M | 1.35M | 0.45% | — |
| 50 | D DEXCOM INC | $24M | 278.0K | 0.44% | — |